Skip to main content
Glama

Assembly outcomes (what else you might have built)

assembly_outcomes
Read-onlyIdempotent

Enumerate the specific wrong plasmids a multi-part Golden Gate or Gibson assembly can produce — a part dropped, inverted, duplicated, two parts swapped, the backbone self-circularised — as full sequences, ranked by how few independent mis-ligations each needs. Golden Gate outcomes are annotated with the MEASURED overhang cross-talk they would have to exploit (Potapov/Pryor ligation data). Feed the result to diagnostic_digest to pick a screening enzyme. Reports no probability per outcome: the ligation data does not measure transformation or vector background.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
namesNoOptional labels for the parts, in the same order ("backbone", "promoter", "CDS"). Used in every outcome label.
enzymeNoGolden Gate only — the Type IIS enzyme, which fixes the overhang length (BsaI, BbsI, Esp3I (BsmBI)).BsaI
methodNoHow the parts are joined. Golden Gate junctions are the Type IIS fusion overhangs; Gibson junctions are the homology arms.goldengate
datasetNoWhich ligation dataset to read overhang cross-talk from (Golden Gate only).generic-t4-37c-1h
circularNoCircular product. Only circular assemblies are covered — a linear product's leading end is a free terminus, not a junction.
fragmentsYesThe parts in assembly order, raw or FASTA — the same list cloning_simulate takes. 2-8 parts.
overlapLenNoGibson only — homology arm length, which must match what the assembly was designed with.
maxAlternativesNoCap on returned alternatives, most accessible first. The pre-cap count is always reported as alternativesEnumerated.

TDQS

A4.4/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

With annotations already declaring readOnlyHint=true and idempotentHint=true, the description adds genuinely valuable behavioral context: outcomes are 'ranked by how few independent mis-ligations each needs,' cross-talk data is explicitly attributed (Potapov/Pryor ligation data), and the limitation is honestly disclosed ('Reports no probability per outcome: the ligation data does not measure transformation or vector background'). This is exactly the kind of caveat-dense behavioral disclosure the annotations can't express.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The opening sentence is information-dense and slightly run-on (though it earns its length by cataloguing failure modes), and the middle sentences are efficient. It's front-loaded with the core purpose and ends with an honest limitation. Minor wordiness like 'the backbone self-circularised' adds color but is justifiable for a molecular biology audience. No waste, but a touch over-long.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given the complexity — 8 parameters, no output schema, two assembly methods, two datasets, and a nuanced cross-talk annotation system — the description is remarkably complete. It explains the ranking principle, data provenance, method-specific behavior, downstream tool integration, and important limitations. The lack of an output schema raises the burden on this description to characterize return behavior (ranked full sequences), which it does well.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 100% with rich detail: enums for method and dataset, defaults documented, cross-tool references ('the same list cloning_simulate takes'), and contextual flags like 'Golden Gate only' and 'Gibson only.' The description adds no parameter-specific semantics not already in the schema, so the baseline of 3 for high-coverage schemas is appropriate.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description pairs a specific verb ('Enumerate') with a precisely-scoped resource ('the specific wrong plasmids a multi-part Golden Gate or Gibson assembly can produce') and catalogs what that entails (dropped, inverted, duplicated, swapped parts; backbone self-circularised). It clearly differentiates from siblings like cloning_simulate (generates intended assemblies) and verify_assembly, while the output direction toward diagnostic_digest disambiguates it from that tool.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives clear workflow guidance ('Feed the result to diagnostic_digest to pick a screening enzyme') and realistic exclusions ('Reports no probability per outcome'), implying when the tool is insufficient. However, it never explicitly names the obvious sibling alternative (cloning_simulate) for the 'intended assembly' case — it says 'the same list cloning_simulate takes' but doesn't say 'if you want the correct plasmid, use X instead.' A named alternative would push this to 5.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.6/5.0
Disambiguation4/5

Most tools have highly specific purposes (e.g., crispr_grna_design vs base_editing_design vs prime_editing_design). However, there is some overlap in sequence analysis tools (characterize_sequence, sequence_report) and plasmid annotation tools (plasmid_annotate vs plasmid_deep_annotate) which could cause confusion.

Naming Consistency3/5

The naming pattern is largely consistent with snake_case verb_noun or noun_descriptor (e.g., primer_design, plasmid_annotate, fastq_trim). However, there are exceptions like 'batch', 'workflow', 'gc_content', and 'cloning_diagnose' which don't follow the verb_noun pattern consistently. Also, some names are phrases like 'golden_gate_from_parts'.

Tool Count2/5

With 101 tools, this server is extremely large and likely overwhelming for agents. Even for a comprehensive bioinformatics toolkit, this exceeds a manageable scope, risking agent confusion and inefficient tool selection. A more modular approach would be advisable.

Completeness4/5

The tool surface covers a wide range of bioinformatics workflows including sequence analysis, primer design, cloning, CRISPR, NGS, expression analysis, and data export. There are minor gaps such as lack of a dedicated protein structure prediction tool and limited off-target genome coverage, but overall the set is impressively complete for its domain.

Resources